May 24, 2016
Washington DC – The American Society for Reproductive Medicine (ASRM) today announced the hiring of Sue Gitlin, PhD as its new Chief Scientific Officer. Dr. Gitlin will join the ASRM staff in September for a transition period and fully assume her duties in 2017.
May 19, 2016
Today the U.S. Senate voted 89-8 to pass HR 2577, an appropriations measure funding Transportation-Housing and Urban Development and related agencies. The bill was combined with a measure to also fund Military Construction and Veterans Affairs, which included a provision giving the Department of VA the funds to begin providing IVF services to wounded veterans in need of assisted reproduction.
April 20, 2016
Please join RESOLVE: The National Infertility Association and ASRM President Dr. Owen Davis for RESOLVE’s annual Advocacy Day event on May 11, 2016 in Washington, DC. RESOLVE’s Advocacy Day brings infertility patients and professionals together to advocate on Capitol Hill for legislation important to our community. This year, RESOLVE hopes to bring more than 200 advocates from all over the country to speak with Members of Congress about infertility issues.
April 14, 2016
Today, the Senate Appropriations Committee passed an amendment to a funding measure to allow the Department of Veterans’ Affairs (VA) to cover the cost of reproductive services, including IVF, for veterans who need infertility treatment due to injuries incurred in their service to our country. Active duty service members injured in this manner have access to IVF care, whereas a longstanding ban on IVF coverage at the VA prevents access for similarly wounded veterans.
April 12, 2016
Washington, DC - Today, The Society for Assisted Reproductive Technology released its latest data on IVF and related procedures. In 2014, 375 SART member clinics performed 190,384 ART cycles and 65,175 babies were delivered using ART from SART clinics. These numbers may be adjusted as results come in from ongoing pregnancies. This is an increase from the 174,962 cycles done in 2013 and the births of 63,286 babies resulting from them.
April 11, 2016
National Infertility Awareness Week (NIAW) is a collaborative effort on the part of the millions of women and men diagnosed with infertility and the nation’s medical, mental health, family building experts and policymakers to raise awareness about infertility.
April 07, 2016
Washington DC – The American Society for Reproductive Medicine (ASRM) today issued a new document “Guidance for Providers Caring for Women and Men of Reproductive Age with Possible Zika Virus Exposure.” The report is intended to help physicians and other health care providers who are treating and counseling patients concerned about Zika’s impact on reproduction.
April 05, 2016
Today, The American Society for Reproductive Medicine (ASRM) released a white paper on the current state of patients’ access to fertility care in the United States and outlining steps we can take to improve that access. At the same time, the Society’s flagship journal, Fertility and Sterility, is publishing online a series of articles addressing specific challenges patients may face when seeking needed fertility care.
March 30, 2016
The American Society for Reproductive Medicine (ASRM) today filed an amicus curiae (friend of the court) brief in McQueen-Gadberry v.Gadberry, a case in Missouri where a now-divorced couple are fighting over dispositional control of embryos created using Assisted Reproductive Technology (ART). The brief does not take a stand as to which party should be granted control. Rather, ASRM's brief is aimed at helping the court assess the "personhood" arguments advanced on appeal by other organizations opposed to ART, including the lack of any biological, ethical, or legal basis for those arguments, and their profoundly negative implications for fertility care.
March 28, 2016
Today, the Food and Drug Administration (FDA) announced emergency approval for a Zika detection and diagnosis test. Federal law allows the FDA to authorize the use of an unapproved medical product or an unapproved use of an approved medical product in certain situations.